Manufacturer record

Sunlife Sciences: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

6 batches manufactured by Sunlife Sciences (Uttarakhand) were declared Not of Standard Quality between March 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

6 records linked to Sunlife Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
6Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2019 to Jun 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

6
NSQ batches since 2019
4
Products affected
Dissolution
Most common failure
Jun 2026
Latest alert

Flagged batches per year

2019 · 22023 · 22025 · 12026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Calcium & Vitamin D3 Tablets IP T-250024Mfg 2025-04 · Exp 2027-03 The sample does not conform to claim as per I.P. 2022 with respect to the test for Assay of Vitamin D3.Assay RDTL, GuwahatiCDSCO lab Jun 2026
Calcium & Vitamin D3 Tablets IP (Calciven-500) T-240267Mfg 2024-06 · Exp 2026-05 Assay of Vitamin D3Assay RDTL GuwahatiCDSCO lab Jun 2025
Myspas (Mefenamic Acid & Dicyclomine HCl Tablets I.P.) T-230764Mfg 2023-09 · Exp 2025-08 DissolutionDissolution CDL KolkataCDSCO lab Dec 2023
BISACODYL GASTRO- RESISTANT TABLETS IP 5 mg T-230766Mfg 2023-09 · Exp 2025-08 DissolutionDissolution CDTL HyderabadCDSCO lab Nov 2023
Atorvastatin Tablets IP (LIPVEN-20 TABLETS) VT-17230Mfg 2017-12 · Exp 2019-11 Dissolution (Atorvastatin Calcium calculated as Atorvastatin)Dissolution RDTL ChandigarhCDSCO lab May 2019
Atorvastatin Tablets IP (LIPVEN-20 TABLETS) VT-17230Mfg 2017-12 · Exp 2019-11 Dissolution (Atorvastatin Calcium calculated as Atorvastatin)Dissolution RDTL ChandigarhCDSCO lab Mar 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.